Startup Originals Team
Ankit Mehrotra and Sahil Jain, the duo behind restaurant-tech startup Dineout, have raised $4.5 million in a seed round for their new venture, The Medical Travel Company (TMTC). The round was led by Nexus Venture Partners with support from athlete-led VC collective 4CAST (co-founded by Ben Stokes, Jofra Archer, and KL Rahul) and several angel investors.
The Funding Round & Investors:
- The seed round was spearheaded by Nexus Venture Partners.
- Participating investors include Kriscore Capital, and 4CAST, backed by cricketers Ben Stokes, Jofra Archer, and KL Rahul.
- Angel investors in the round include:
- Sriharsha Majety (Swiggy)
- Abhishek Goyal (Tracxn)
- Dr. Ritesh Malik (Innov8)
- Manish Vij (Smile Group)
- Arjun Vaidya (V3 Ventures)
- Also participation from 1947 Rise Fund and Peercheque
What The Medical Travel Company Does:
TMTC is a cross-border medical travel platform offering UK patients access to quality healthcare in India with full oversight and continuity of care.
Key features of its model include:
- UK doctor oversight: Patients retain involvement of UK doctors before, during, and after treatment.
- Accredited care in India: Hospitals meet JCI / NABH accreditation standards.
- Post-surgery insurance: TMTC offers a 12-month insurance policy valid in the UK for patients returning after treatment.
- End-to-end logistics & aftercare: The startup handles rehabilitation, travel, and supportive services as part of a seamless patient journey.
One of the motivations behind this business is the long wait times in the UK healthcare system: currently, 7.7 million people in the UK wait for elective procedures. TMTC aims to offer faster and cost-effective alternatives via its India connection.
Founders & Their Background:
- Ankit Mehrotra and Sahil Jain previously built Dineout, which was acquired by Swiggy in 2022.
- Their experience in consumer tech and scaling operations is expected to help TMTC in managing patient acquisition, operations, and trust.
- As they build TMTC, they emphasize that medical travel is a broken industry, characterised by fragmentation, hidden costs, and poor post-treatment support.
Use of Funds & Expansion Plans:
- The raised capital will be used to enhance digital patient management systems, expand clinical partnerships in India, and scale operations in the UK.
- Over the next 3-4 years, TMTC plans to expand to additional geographies: US, Canada, Australia, and Europe.
